Concepedia

Author

Shanti M. Amagasu

Theravance Biopharma (United States)

Also Known As

S Amagasu, S. Amagasu, S. M. Amagasu, S.M. Amagasu, Shanti Amagasu, Shanti M Amagasu, Shanti M. Amagasu, Shanti M. Amagasu

22

Publications

642

Citations

13

H-Index

37

Concepts

All Affiliations

Theravance Biopharma (United States)Amgen (United States)Stanford University
SM

About

Shanti M. Amagasu is an author at Theravance Biopharma (United States) specializing in medicine, physiology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

201

2

Social Sciences

3

3

155

3

Cellular Physiology

3

3

72

4

Biochemistry

2

2

57

5

Endocrinology

1

1

15

Shanti M. Amagasu

×

13

Publications

639

Citations

13

H-Index

YearCitations

Volatile Anesthetics Depress Glutamate Transmission Via Presynaptic Actions

Bruce M. MacIver, Anthony A. Mikulec, Shanti M. Amagasu,

Anesthesiology

1996

195

Characterization of prostanoid receptor‐evoked responses in rat sensory neurones

Jacqueline A.M. Smith, Shanti M. Amagasu, Richard M. Eglen,

British Journal of Pharmacology

1998

98

Riluzole Anesthesia

M Bruce MacIver, Shanti M. Amagasu, Anthony A. Mikulec,

Anesthesiology

1996

54

Halothane depresses action potential conduction in hippocampal axons

Anthony A. Mikulec, Sky Pittson, Shanti M. Amagasu,

Brain Research

1998

49

Discovery of a selective, state-independent inhibitor of NaV1.7 by modification of guanidinium toxins

Hassan Pajouhesh, Jacob T. Beckley, Anton Delwig,

Scientific Reports

2020

40

AZD-3043

Talmage D. Egan, Shinju Obara, Thomas E. Jenkins,

Anesthesiology

2012

34

Comparison of the Pharmacological Properties of Rat Na<sub>V</sub>1.8 with Rat Na<sub>V</sub>1.2a and Human Na<sub>V</sub>1.5 Voltage-Gated Sodium Channel Subtypes Using a Membrane Potential Sensitive Dye and FLIPR<sup>R</sup>

R. Vickery, Shanti M. Amagasu, Ray Chang,

Receptors and Channels

2004

33

An in vitro investigation of the cardiovascular effects of the 5-HT4 receptor selective agonists, velusetrag and TD-8954

David T. Beattie, Deborah L. Higgins, Mike Ero,

Vascular Pharmacology

2012

31

Discovery of Tarantula Venom-Derived Na<sub>V</sub>1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis

Bin Wu, Justin K. Murray, Kristin L. Andrews,

Journal of Medicinal Chemistry

2018

31

Comparison of the Pharmacological Properties of Rat NaV1.8 with Rat NaV1.2a and Human NaV1.5 Voltage-Gated Sodium Channel Subtypes Using a Membrane Potential Sensitive Dye and FLIPRR

R. Vickery, Shanti M. Amagasu, Ray Chang,

Receptors and Channels

2004

24

Page 1